Skip to main content
. 2019 Apr 18;4(8):1057–1065. doi: 10.1016/j.ekir.2019.04.011

Figure 2.

Figure 2

(a,b,c) No significant difference in the risk of rejection on subsequent biopsies between donor-specific antibody (DSA)+ and DSA− groups. ABMR, antibody-mediated rejection; TCMR, T-cell–mediated rejection.